Psoriasis and Depression
Psoriasis is a common skin disorder and associated with significant Psychosocial comorbidities including depression, and suicidal ideations.
Go to Lecture 
Prof. Mohammad Jafferanyis a trained dermatologist and psychiatrist. He completed his residency at Hennepin County Medical Center in Minneapolis, Minnesota and at the University of Washington in Seattle. He is a member of various professional organizations. He is Executive Secretary of the Association for Psychoneurocutaneous Medicine of North America. He is the past Deputy Editor of Dermatologic therapy Journal. Psychodermatology is his area of interest and research. Disorders such as trichotillomania, peeling of the skin, and psychogenic itching are some of the issues in this area that are of great interest to him. In addition to medication management, he also uses other treatment modalities such as cognitive-behavioral therapy, psychodynamic therapy, supportive psychotherapy, and habit reversal therapy. He has led various psychodermatology workshops in different parts of the world. He is a regular guest speaker at international conferences to speak on psychodermatology topics. He has edited four books and two author’s books on various branches of psychodermatology:
- Pediatric psychodermatology (editor)
- Geriatric psychodermatology (editor)
- Stress and skin disorders (editor)
- Trichotillomania (editor)
- Essentials of Psychodermatology (Author)
- Psychodermatology: Basic Concepts (Author)
- Author of the chapter on psychocutaneous medicine, in three textbooks
Its treatment philosophy includes a bio-psycho-social model, with more emphasis on exploring the factors leading to the current problem in the context of family, interpersonal relationships and various other psychosocial stressors. Medication is often a very important part of treatment, but in combination with therapy, they work more effectively. His approach to medication in children and adolescents is conservative. When psychotherapy and behavioral interventions are not helpful, medications can be tried at a minimal dose.
PUBLICATIONS: Prof. Mohammad Jafferany currently has 146 peer-reviewed publications in scientific journals.